38,904 Shares in Synopsys, Inc. $SNPS Purchased by Carnegie Investment Counsel

Carnegie Investment Counsel bought a new stake in Synopsys, Inc. (NASDAQ:SNPS) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 38,904 shares of the semiconductor company’s stock, valued at approximately $19,195,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SNPS. Comprehensive Financial Consultants Institutional Inc. lifted its stake in Synopsys by 42.4% in the third quarter. Comprehensive Financial Consultants Institutional Inc. now owns 4,643 shares of the semiconductor company’s stock valued at $2,291,000 after acquiring an additional 1,383 shares during the last quarter. Burney Co. grew its position in Synopsys by 4.1% in the 3rd quarter. Burney Co. now owns 5,977 shares of the semiconductor company’s stock worth $2,949,000 after purchasing an additional 235 shares during the last quarter. Asio Capital LLC increased its stake in Synopsys by 5.7% during the third quarter. Asio Capital LLC now owns 6,450 shares of the semiconductor company’s stock valued at $3,182,000 after acquiring an additional 350 shares during the period. Regent Peak Wealth Advisors LLC bought a new position in Synopsys in the third quarter worth $202,000. Finally, HBK Sorce Advisory LLC boosted its stake in Synopsys by 10.4% during the third quarter. HBK Sorce Advisory LLC now owns 937 shares of the semiconductor company’s stock worth $462,000 after buying an additional 88 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently issued reports on SNPS. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their price target for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. The Goldman Sachs Group lowered their price target on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Morgan Stanley upped their target price on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Wells Fargo & Company lifted their price target on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a report on Thursday, December 11th. Finally, Citigroup started coverage on shares of Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 target price for the company. Eleven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $562.13.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $477.14 on Friday. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The firm has a market cap of $91.29 billion, a PE ratio of 59.72, a PEG ratio of 3.96 and a beta of 1.16. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a fifty day moving average price of $437.58 and a 200 day moving average price of $503.61.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the prior year, the company posted $3.40 earnings per share. The firm’s revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Activity

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.62% of the company’s stock.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.